Skip to main
HCA
HCA logo

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 23%
Buy 38%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

HCA Healthcare's strong financial outlook is bolstered by its status as the largest integrated healthcare delivery system in the United States, providing unmatched scale and infrastructure. The company anticipates growth in the fourth quarter, driven by year-over-year contributions from Mission Health, which is expected to surpass the impacts of prior disruptions. Additionally, the approval of the TN program is anticipated to positively affect third-quarter earnings, further enhancing the company's financial position.

Bears say

HCA Healthcare faces significant headwinds, including a projected 5% decline in earnings estimates for 2026, alongside an anticipated contraction in its valuation multiple to 8.0x. This negative outlook is further compounded by management's expectation of a decrease of approximately $130 million in DPP contributions year-over-year in the second half, primarily due to the comparative performance in the fourth quarter. Additionally, the recent adjustment of the enterprise multiple to 9.25x from 9.5x underscores concerns regarding EBITDA growth sustainability moving forward.

HCA Healthcare (HCA) has been analyzed by 13 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 38% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 13 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $422.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $422.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.